Crescendo Reached on Long-standing Quest for FDA Regulation of Laboratory-developed Tests

The FDA made official in 2010 its intent to revise its previous LDT policy (in which there effectively was none), citing insufficient evidence in claims of an LDT’s efficacy, a lack of controls, yielding false results, or developers fudging numbers and producing fake results. While there has been a fair amount of FDA statements since 2010, In the absence of action, we see a thriving market.


Retail Clinics a Factor in CVS-Aetna Merger

Retail Clinics a Factor in CVS-Aetna Merger

Retail clinics should get a boost both in recognition of concept, and in clinic numbers as a result of the recent $69 billion-dollar CVS- Aetna deal and the expressed interest of CVS to be the 'front door" of healthcare. CVS is the largest provider of retail clinics and the addition of a healthcare insurer signals increased usage. There's plenty of reasons why there's room to grow for clinics, as well as other alternative healthcare services. We take a look at some of the current stats on in-store clinics from our report earlier this year.